The results showed that the high expression of RAB5B was associated with high survival rate (88.46%) and low response rate to anti-PD-1 therapy (only 11.54%) in patients with urinary system tumors, as shown in Figure 6C. The gene discussed is RAB5B; the disease is urinary system neoplasm.